Neuropeptide degrading enzyme(s) in plasma and brain: effects of in vivo neuroleptic administration.
D000626:Aminopeptidases / Q000097:blood / Q000378:metabolism*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000201:enzymology; D004723:Endorphins / Q000378:metabolism*; D004745:Enkephalins / Q000378:metabolism*; D005476:Fluphenazine / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008658:Inactivation, Metabolic; D051379:Mice; D010447:Peptide Hydrolases / Q000097:blood / Q000378:metabolism
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D004723:Endorphins; D004745:Enkephalins; D010447:Peptide Hydrolases; D000626:Aminopeptidases; D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine